3,031
Views
16
CrossRef citations to date
0
Altmetric
Article

The perverse impact of external reference pricing (ERP): a comparison of orphan drugs affordability in 12 European countries. A call for policy change

, & ORCID Icon
Article: 1369817 | Received 17 May 2017, Accepted 03 Aug 2017, Published online: 03 Sep 2017

Figures & data

Figure 1. Unadjusted annual cost ratios using the UK as a reference.

Figure 1. Unadjusted annual cost ratios using the UK as a reference.

Figure 2. Relative cost ratios: adjusted using nominal GDP per capita (UK reference = 1).

Figure 2. Relative cost ratios: adjusted using nominal GDP per capita (UK reference = 1).

Figure 3. Relative cost ratios: adjusted using GDP in PPP per capita (UK reference = 1).

Figure 3. Relative cost ratios: adjusted using GDP in PPP per capita (UK reference = 1).

Figure 4. Relative cost ratios: adjusted using % GPD contributed by the government (UK reference = 1).

Figure 4. Relative cost ratios: adjusted using % GPD contributed by the government (UK reference = 1).

Figure 5. Relative cost ratios: adjusted using government budget per inhabitant (UK reference = 1).

Figure 5. Relative cost ratios: adjusted using government budget per inhabitant (UK reference = 1).

Figure 6. Relative cost ratios: adjusted using % GPD spent on healthcare (UK reference = 1).

Figure 6. Relative cost ratios: adjusted using % GPD spent on healthcare (UK reference = 1).

Figure 7. Relative cost ratios: adjusted using % GPD spent on pharmaceuticals (UK reference = 1).

Figure 7. Relative cost ratios: adjusted using % GPD spent on pharmaceuticals (UK reference = 1).

Figure 8. Relative cost ratios: adjusted using average annual salary per inhabitant (UK reference = 1).

Figure 8. Relative cost ratios: adjusted using average annual salary per inhabitant (UK reference = 1).
Supplemental material

The_Perverse_impact_of_ERP_SUPP.docx

Download MS Word (23.8 KB)